Nurix Therapeutics at TPD Summit 2026
Oct 26–29, 2026 Boston, MA ~300 attendees Website
Nurix Therapeutics takes part in 4 sessions at TPD Summit 2026 in Boston. Its program spans the business and clinical sides of protein degradation, from where the induced proximity field and its investors are heading to lessons from its own degraders in cancer and immune disease.
| Organization | TPD Summit 2026 Attendance |
|---|---|
Nurix Therapeutics San Francisco, CA | ◇Industry Partner |
Clinical-stage biotech developing targeted protein degraders, including BTK degraders, for cancer and inflammatory diseases. | Panel Tue Oct 27 9:00am Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact Investment, partnering & strategy Talk Tue Oct 27 12:30pm Panel Wed Oct 28 10:00am Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding Investment, partnering & strategy Talk Thu Oct 29 9:00am Session Details to be Announced AI & computational design |
Instantly find 20 buyers from Nurix Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction